Cart
sales@molnova.com
Pyributicarb
CAS No. 88678-67-5
Pyributicarb ( TSH-888 )
Catalog No. M20997 CAS No. 88678-67-5
Pyributicarb is a potent activator of both CYP3A4 gene and human pregnane X receptor (hPXR).?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 43 | Get Quote |
|
| 50MG | 65 | Get Quote |
|
| 100MG | 95 | Get Quote |
|
| 200MG | 140 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePyributicarb
-
NoteResearch use only not for human use.
-
Brief DescriptionPyributicarb is a potent activator of both CYP3A4 gene and human pregnane X receptor (hPXR).?
-
DescriptionPyributicarb is a potent activator of both CYP3A4 gene and human pregnane X receptor (hPXR).?
-
SynonymsTSH-888
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP3A4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88678-67-5
-
Formula Weight330.44
-
Molecular FormulaC18H22N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (302.63 mM)
-
SMILESCOc1cccc(N(C)C(=S)Oc2cccc(C(C)(C)C)c2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Matsubara T Noracharttiyapot W Toriyabe T et al. Assessment of Human Pregnane X Receptor Involvement in Pesticide-Mediated Activation of CYP3A4 Gene[J]. Drug Metabolism and Disposition 2007 35(5):728-733.
molnova catalog
related products
-
PIK75
PIK-75 Hydrochloride is a p110α inhibitor with IC50 of 5.8 nM (200-fold more potently than p110β), isoform-specific mutants at Ser773, and also potently inhibits DNA-PK with IC50 of 2 nM in cell-free assays.
-
Furafylline
Furafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
-
Rhodionin
Rhodionin and rhodionin can inhibit cytochrome P450 2D6 non-competitively with high specificity which could have implications for interactions with co-administered drugs; they can significantly suppress the elevation of the postprandial blood triglyceride level suggests that they may be to the treatment of lifestyle-related diseases such as hyperlipidemia and exogeneous obesity and to health foods.
